Search
Sulfamoxole
go.drugbank.com/drugs/DB08798ExperimentalSulfamoxole is an antibacterial in the sulfonamide class.
Categories: sulfamoxole and trimethoprim, Sulfonamides and trimethoprimSynonyms: N1-(4,5-Dimethyl-2-oxazolyl)sulfanilamide, N(sup 1)-(4,5-Dimethyl-2-oxazolyl)sulfanilamideGalunisertib
go.drugbank.com/drugs/DB11911InvestigationalGalunisertib has been used in trials studying the basic science and treatment of Glioma, Neoplasms, Solid Tumor, GLIOBLASTOMA, and Prostate Cancer, among others.
Lapachone
go.drugbank.com/drugs/DB11948InvestigationalLapachone has been used in trials studying the treatment of Cancer, Carcinoma, Advanced Solid Tumors, Head and Neck Neoplasms, and Carcinoma, Squamous Cell.
Regrelor
go.drugbank.com/drugs/DB05553InvestigationalCategories: Nucleic Acids, Nucleotides, and NucleosidesGalicaftor
go.drugbank.com/drugs/DB14894InvestigationalGalicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737
ZB131
go.drugbank.com/drugs/DB17164InvestigationalZB131 is a monoclonal antibody with a high affinity and specificity for cancer-specific plectin (CSP), a cell surface protein identified in a wide range of cancers that correlates with poor prognosis and
Piritrexim
go.drugbank.com/drugs/DB03695InvestigationalPiritrexim has been used in trials studying the treatment of Bladder Cancer, Urethral Cancer, and Transitional Cell Cancer of the Renal Pelvis and Ureter.
Octacosanol
go.drugbank.com/drugs/DB11220InvestigationalNutraceuticalproperties, cytoprotective use, and ergogenic properties [A27245]. … This high–molecular-weight organic compound is the main component of a natural product wax extracted from plants [A27245]. 1-octacosanol is reported to possess cholesterol-lowering effects, antiaggregatory
Synonyms: n-octacosanolXmAb24306
go.drugbank.com/drugs/DB17526InvestigationalXmAb24306 is an investigational cancer immunotherapy. It is a heterodimeric interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) complex fused to a bispecific Fc domain.